John F. Thero

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bedminster, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David Gaiero, as attorney-in-fact for John F. Thero
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John F. Thero

Form 4 holding President and CEO, Director

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
3,252,752
Estimated value
$3,545,500
Report date
30 Jul 2021
Price
$1.09
Ownership
Direct
Form 4 holding President and CEO, Director

AMARIN CORP PLC\UK

Security class
Restricted Stock Units
Shares / value
13,472
Estimated value
Report date
30 Jul 2021
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

CHIASMA, INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CinCor Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cyteir Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
08 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John F. Thero

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .